By Clara MacKay, CEO, World Ovarian Cancer Coalition It was great to be back in Chicago for this year’s American Society of Clinical Oncology (ASCO) meeting. A highlight of these meetings is always the opportunity to meet with leaders in the global cancer advocacy movement and 2025 did not disappoint! I was able to […]
Read More >
The June issue of the Journal of Cancer Policy includes the recent qualitative study with clinicians conducted as part of the multi-country observational Every Woman Study™ (EWS). Semi-structured interviews were conducted with clinicians between June 2022 and June 2023. The interview guide was developed by the EWS LMIC Oversight Committee, including patients, clinicians and data […]
Read More >
By Clara MacKay, CEO, World Ovarian Cancer Coalition 24 March 2025 The Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer is an important touchpoint for the entire community – clinicians, researchers, and those of us in advocacy. A key opportunity to learn about the latest advancements in gynecologic cancer treatment and research. With no […]
Read More >
2 February 2025 I had a great opportunity last week to showcase the Every Woman Study, low- and middle-income (LMIC) edition at the European Society for Gynaecologic Oncology Meeting in Rome, with a poster outlining potentially novel indicators for optimal cytoreductive surgery beyond age and stage of disease on diagnosis. Using data from 2446 women […]
Read More >
As I step into the role of Chair for the World Ovarian Cancer Coalition, I feel deeply honored and incredibly energized. The shoes I have to fill are significant, but I’ve had the privilege of learning from the best—Elizabeth Baugh and Annwen Jones OBE. Their leadership has shaped the Coalition into the impactful organization it […]
Read More >
Annwen Jones OBE When I look back on 2024, it will be as a year of profound emotion—a time of hope, progress, and poignancy. It began with a shocking forecast: based on the latest GLOBOCAN data, by 2050, 12 million women will face an ovarian cancer diagnosis, with 8 million of them tragically losing their […]
Read More >
Over the past few weeks, I’ve had the privilege of attending two transformative global cancer meetings: the European Society of Medical Oncology (ESMO) Congress and the Union for International Cancer Control (UICC) World Cancer Congress. These experiences have left me feeling inspired and also deeply moved. I believe that these gatherings not only highlight advancements […]
Read More >
Our recent World Ovarian Cancer Coalition Board of Directors meeting started in the usual way, with a short video from someone with personal experience of ovarian cancer. Lucía, from Guatemala, is a beautiful, bright, recently married, young mother living with ovarian cancer that has now spread. She spoke clearly and eloquently about not knowing even […]
Read More >
As organisations and individuals we’ve faced considerable challenges over the past few years. Yet, as we approach the final days of 2023, I find myself deeply thankful for the resilience and commitment shown by my colleagues worldwide. Despite ongoing difficulties such as the escalating cost of living, global conflicts, and the impacts of climate change, […]
Read More >
Clara MacKay, CEO In 2021, when the World Ovarian Cancer Coalition surveyed our advocacy partner organizations about what topics they would like to see on the agenda for our inaugural Partner Meeting, 2SLGBTIQA+/LGBTIQA+ inclusiveness was a frontrunner topic. Many of the organizations that we work with do outstanding work in this area. However, and encouragingly […]
Read More >